Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Synta Pharmaceuticals discloses Hsp90 inhibitors for the treatment of cancer

Jan. 22, 2010

Everolimus effective in patients with metastatic pancreatic neuroendocrine tumors

Jan. 22, 2010

Banyu and Merck & Co. claim novel Akt1 inhibitors for cancer therapy

Jan. 22, 2010

Phase II data show ixabepilone to be safe and efficacious in ovarian cancer

Jan. 21, 2010

Spear Therapeutics discloses novel compounds for cancer treatment

Jan. 21, 2010

Sunitinib activity limited in patients with squamous cell carcinoma of the head and neck

Jan. 21, 2010

EMEA Pediatric Committee grants product-specific waivers for StemEx

Jan. 21, 2010

GenVec reports key event in phase III trial of TNFerade in advanced pancreatic cancer

Jan. 21, 2010

Smo receptor antagonists described by Amgen for cancer therapy

Jan. 21, 2010

Novel delivery system for targeted radiotherapy of breast cancer shows promise in vitro

Jan. 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...